Skip to main content
. 2013 May 29;305(2):E243–E253. doi: 10.1152/ajpendo.00044.2013

Fig. 2.

Fig. 2.

ET and RESV improve exercise performance during concurrent DOX treatment. A: citrate synthase activity; B: distance to fatigue during an endurance test; C: time to fatigue during an endurance test. Values are means ± SE (n = 9–10). *P < 0.05, value for difference vs. CON group; §P < 0.05, value for DOX vs. DOX + ET or DOX + RESV groups; †P < 0.05, value for DOX + ET vs. DOX + RESV groups.